Laboratorios Farmaceuticos Rovi, S.A. Share Price
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
Pre-market 10:41:00 am | |||
| 58.05 EUR | -0.26% |
|
59.05 | +1.72% |
| 13/05 | Spanish stocks - Factors to watch on May 13 | RE |
| 09/05 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 296.92Cr 342.16Cr 273.7Cr 256.46Cr 479.17Cr 33TCr 489.15Cr 3.26TCr 1.26TCr 16TCr 1.28TCr 1.26TCr 55TCr | P/E Ratio 2026 * |
22.2x | P/E Ratio 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 294.67Cr 339.56Cr 271.62Cr 254.51Cr 475.53Cr 33TCr 485.43Cr 3.24TCr 1.25TCr 16TCr 1.27TCr 1.25TCr 54TCr | EV / Sales 2026 * |
3.81x | EV / Sales 2027 * | 3.15x |
| Free-Float |
31.8% | Yield 2026 * |
1.68% | Yield 2027 * | 2.02% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | +1.72% | ||
| 1 week | -1.61% | ||
| Current month | -2.11% | ||
| 1 month | -6.52% | ||
| 3 months | -27.30% | ||
| 6 months | -6.14% | ||
| Current year | -8.58% |
| 1 week | 57.6 |  | 59.05 |
| 1 month | 57.4 | | 61.1 |
| Current year | 57.4 | | 86.7 |
| 1 year | 51.65 | | 86.7 |
| 3 years | 37.96 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Tech/Sci/R&D Officer | - | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/23/23 | Buy | Director | 1,000 | 0.0019% | ||
| 13/22/13 | Norbel Inversiones SL
| Sell | Company | 5,60,690 | 1.0000% | |
| 15/22/15 | Norbel Inversiones SL
| Sell | Company | 28,03,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | -1.61% | +2.74% | +32.84% | 342.16Cr | |
| +2.16% | +3.17% | +43.57% | +160.28% | 1,03500Cr | |
| -0.07% | +4.45% | +53.50% | +48.95% | 57TCr | |
| -0.08% | -0.08% | +17.37% | +62.66% | 40TCr | |
| +0.77% | +0.77% | +21.19% | +15.95% | 32TCr | |
| +0.85% | +0.18% | +24.50% | +15.93% | 28TCr | |
| +2.10% | +4.92% | +25.30% | +34.79% | 28TCr | |
| -0.19% | -0.46% | -45.32% | -48.23% | 19TCr | |
| +4.84% | +2.45% | +21.33% | +61.85% | 19TCr | |
| +3.61% | -2.56% | +15.16% | +61.12% | 16TCr | |
| Average | +1.57% | +1.35% | +17.94% | +44.61% | 34.33TCr | |
| Weighted average by Cap. | +1.37% | +2.38% | +29.48% | +72.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 89Cr 71Cr 67Cr 124.91Cr 8.54TCr 127.51Cr 851.1Cr 329.52Cr 4.12TCr 334.83Cr 327.62Cr 14TCr | 91Cr 105.22Cr 84Cr 79Cr 147.36Cr 10TCr 150.42Cr 1TCr 388.73Cr 4.86TCr 395Cr 386.49Cr 17TCr |
| Net income | 13Cr 15Cr 12Cr 11Cr 21Cr 1.47TCr 22Cr 146.23Cr 57Cr 707.29Cr 58Cr 56Cr 2.46TCr | 18Cr 21Cr 17Cr 16Cr 29Cr 2.01TCr 30Cr 200.76Cr 78Cr 971.08Cr 79Cr 77Cr 3.38TCr |
| Net Debt | -2.25Cr -2.6Cr -2.08Cr -1.95Cr -3.64Cr -248.62Cr -3.71Cr -25Cr -9.59Cr -119.84Cr -9.75Cr -9.54Cr -416.7Cr | -9.05Cr -10Cr -8.34Cr -7.82Cr -15Cr -998.81Cr -15Cr -100Cr -39Cr -481.46Cr -39Cr -38Cr -1.67TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | 58.05 € | -0.26% | 79,626 |
| 10/26/10 | 58.20 € | +1.04% | 1,26,813 |
| 09/26/09 | 57.60 € | -1.87% | 72,651 |
| 08/26/08 | 58.70 € | -0.17% | 89,571 |
| 05/26/05 | 58.80 € | -0.34% | 86,503 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
